N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS:477600-73-0
N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine plays a significant role in medicinal chemistry and pharmaceutical research due to its unique chemical properties. In drug discovery and development, it serves as a lead compound or pharmacological probe for the design and synthesis of novel therapeutics targeting specific biological pathways or disease conditions. Moreover, this compound exhibits potential applications in the treatment of neurological disorders and psychiatric conditions. By modulating neuronal signaling pathways or neurotransmitter systems, it may exert therapeutic effects in the management of disorders such as schizophrenia, depression, or Alzheimer's disease. Research efforts focus on elucidating its pharmacological mechanisms and assessing its efficacy and safety profiles for clinical applications in neurological and psychiatric therapeutics. Furthermore, N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine finds utility in oncology research and cancer therapy. Its ability to target specific molecular targets or signaling pathways implicated in cancer progression makes it a promising candidate for the development of anticancer drugs. Research studies aim to evaluate its anti-proliferative, cytotoxic, and anti-metastatic properties in preclinical models of cancer, paving the way for potential clinical translation in cancer treatment. Additionally, this compound serves as a valuable tool in chemical biology and pharmacological research. Its structural complexity and pharmacological activity allow researchers to explore its interactions with biological targets, elucidate molecular mechanisms of action, and identify potential drug candidates for various therapeutic indications. Moreover, N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine may find applications in drug metabolism and pharmacokinetic studies. Its metabolic stability, bioavailability, and pharmacokinetic properties are evaluated to assess its suitability as a drug candidate and optimize its pharmacological profile for therapeutic use. Overall, the multifaceted nature of N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine makes it invaluable in medicinal chemistry, pharmacological research, and drug discovery. Its potential applications span from neurological and psychiatric therapeutics to oncology research and drug metabolism studies, highlighting its significance in advancing scientific knowledge and innovation in the field of pharmaceutical sciences.
Composition | C22H27N5 |
Assay | 99% |
Appearance | white powder |
CAS No. | 477600-73-0 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |